Jathin Bandari - 10 Jan 2022 Form 4/A - Amendment Insider Report for Protara Therapeutics, Inc. (TARA)

Role
Chief Medical Officer
Signature
/s/ Mary Grendell, Attorney-in-Fact
Issuer symbol
TARA
Transactions as of
10 Jan 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
09 Mar 2022, 15:33:31 UTC
Date Of Original Report
12 Jan 2022
Next filing
05 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TARA Common Stock 21,000 10 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 12, 2022, the Reporting Person filed a Form 4 which inadvertently reported that, following the issuance of a restricted stock unit award, he directly owned 13,500 shares of the Issuer's common stock. In fact, as reported in this amendment, the Reporting Person directly owned 21,000 shares of common stock.